Recently published Wet AMD Market Insights report includes a comprehensive understanding of current treatment practices, wet ...
A single injection of the tyrosine kinase inhibitor hydrogel has demonstrated superiority to aflibercept 2 mg in maintaining visual acuity and providing higher rescue-free rates through 1 year in ...
Wet age-related macular degeneration advances much more rapidly than the dry form, potentially causing significant vision decline within days to weeks without treatment. Anti-VEGF injections ...
EyePoint Pharmaceuticals’ investigational therapy for wet age-related macular degeneration (wet AMD) was effective in a Phase 2 trial, the company announced Monday. The announcement was welcome news ...
An intravitreal insert provides durable control of multiple retinal diseases, according to a presentation at Retina World ...
Barbara Kellermueller doesn’t let wet AMD get in the way of her active lifestyle, which includes being the designated driver for her friends. She shares how she stays independent with the condition.
Please provide your email address to receive an email when new articles are posted on . EYP-1901 and OTX-TKI have shown results similar to aflibercept 2 mg. Gene therapy is another type of treatment ...
—A new analysis took a 2-prong approach to assessing risk factors for wet age-related macular degeneration: a systematic review of the literature, coupled with a study of decades’ worth of data from ...